GB1548984A - Calcitonin peptide preparations with prolonged action - Google Patents

Calcitonin peptide preparations with prolonged action

Info

Publication number
GB1548984A
GB1548984A GB21405/76A GB2140576A GB1548984A GB 1548984 A GB1548984 A GB 1548984A GB 21405/76 A GB21405/76 A GB 21405/76A GB 2140576 A GB2140576 A GB 2140576A GB 1548984 A GB1548984 A GB 1548984A
Authority
GB
United Kingdom
Prior art keywords
prolonged action
peptide preparations
calcitonin peptide
calcitonin
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB21405/76A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of GB1548984A publication Critical patent/GB1548984A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
GB21405/76A 1975-05-26 1976-05-24 Calcitonin peptide preparations with prolonged action Expired GB1548984A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH671975 1975-05-26

Publications (1)

Publication Number Publication Date
GB1548984A true GB1548984A (en) 1979-07-18

Family

ID=4313966

Family Applications (1)

Application Number Title Priority Date Filing Date
GB21405/76A Expired GB1548984A (en) 1975-05-26 1976-05-24 Calcitonin peptide preparations with prolonged action

Country Status (14)

Country Link
JP (1) JPS51144721A (enExample)
AU (1) AU507537B2 (enExample)
BE (1) BE842189A (enExample)
CA (1) CA1098444A (enExample)
DE (1) DE2623074A1 (enExample)
FR (1) FR2312260A1 (enExample)
GB (1) GB1548984A (enExample)
HK (1) HK15982A (enExample)
IE (1) IE43770B1 (enExample)
IL (1) IL49653A (enExample)
MY (1) MY8200284A (enExample)
NL (1) NL7605559A (enExample)
NZ (1) NZ180945A (enExample)
ZA (1) ZA763096B (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115627A1 (en) * 1982-12-29 1984-08-15 Armour Pharmaceutical Company Enhancement of intranasal absorption of calcitonin by formulation with surfactants
GB2190838A (en) * 1986-05-27 1987-12-02 Sandoz Ltd Pharmaceutical compositions containing polypeptides
GB2200048A (en) * 1986-12-19 1988-07-27 Sandoz Ltd Pharmaceutical colloidal hydrosols for injection
WO2023089240A1 (en) * 2021-11-19 2023-05-25 Nanoform Finland Oyj A composition comprising nanosized active pharmaceutical ingredient

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions
GB9120672D0 (en) * 1991-09-28 1991-11-06 Ciba Geigy Ag Pharmaceutical compositions
IT1255895B (it) * 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
CA2321924A1 (en) * 1998-02-25 1999-09-02 Abbott Laboratories Butorphanol sustained release formulations

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0115627A1 (en) * 1982-12-29 1984-08-15 Armour Pharmaceutical Company Enhancement of intranasal absorption of calcitonin by formulation with surfactants
GB2190838A (en) * 1986-05-27 1987-12-02 Sandoz Ltd Pharmaceutical compositions containing polypeptides
GB2190838B (en) * 1986-05-27 1990-12-12 Sandoz Ltd Pharmaceutical compositions
GB2200048A (en) * 1986-12-19 1988-07-27 Sandoz Ltd Pharmaceutical colloidal hydrosols for injection
GB2200048B (en) * 1986-12-19 1991-02-06 Sandoz Ltd Hydrosols of pharmacologically active agents and pharmaceutical compositions comprising them
WO2023089240A1 (en) * 2021-11-19 2023-05-25 Nanoform Finland Oyj A composition comprising nanosized active pharmaceutical ingredient

Also Published As

Publication number Publication date
AU507537B2 (en) 1980-02-21
MY8200284A (en) 1982-12-31
NL7605559A (nl) 1976-11-30
CA1098444A (en) 1981-03-31
IL49653A0 (en) 1976-07-30
JPS51144721A (en) 1976-12-13
BE842189A (fr) 1976-11-25
DE2623074A1 (de) 1976-12-09
NZ180945A (en) 1978-07-10
FR2312260A1 (fr) 1976-12-24
IL49653A (en) 1979-07-25
HK15982A (en) 1982-04-08
AU1425276A (en) 1977-12-01
IE43770L (en) 1976-11-26
FR2312260B1 (enExample) 1978-12-08
IE43770B1 (en) 1981-05-20
ZA763096B (en) 1978-01-25

Similar Documents

Publication Publication Date Title
PT64743A (en) Peptides
AU508162B2 (en) Calcitonin analogues
JPS52131578A (en) Novel peptide and preparation thereof
JPS5219658A (en) Novel peptide compound
IL48862A0 (en) Polypeptides
GB1549214A (en) Stroma-free haemoglobin
JPS5231073A (en) Peptide and intermediate thereof
PH14917A (en) Anti-bacterial peptide
ZA765817B (en) Biological preparations
JPS51125395A (en) Polypeptide
GB1548984A (en) Calcitonin peptide preparations with prolonged action
GB1546517A (en) Polypeptides
JPS51138697A (en) Amino substituted cephlosporins
JPS51130425A (en) Colddwaterrsoluble preparations
JPS5276441A (en) Polypeptide for cosmetic
PH13361A (en) Engot peptide alkacids
JPS53111060A (en) Alphaaaminoxyacyl grouppcontaining peptide
GB1541710A (en) Anthelintic preparations
ZA754234B (en) Antifungal preparations
AU514308B2 (en) Polypeptide agents
GB1545818A (en) Peptides
IE44541L (en) Chemically modified polypeptides
GB1544906A (en) Protein materials
JPS527417A (en) Direct pressed excipien
JPS51133434A (en) Sunscreen preparations

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee